Castle Biosciences Honored with a Greater Pittsburgh Top Workplaces 2025 Award
Castle Biosciences (Nasdaq: CSTL) has been named a Greater Pittsburgh Top Workplace by The Pittsburgh Post-Gazette, based on anonymous employee feedback. The recognition evaluates workplace culture factors including employee support, growth opportunities, and empowerment.
The company has garnered multiple workplace accolades in 2025, including Top Workplaces USA (fourth consecutive year), ranking third in the Healthcare Industry category, and receiving five Culture Excellence Awards for Innovation, Work-Life Flexibility, Compensation & Benefits, Leadership, and Purpose & Values.
Castle Biosciences (Nasdaq: CSTL) è stata designata come uno dei principali posti di lavoro della Greater Pittsburgh dall'informativa anonima dei dipendenti del Pittsburgh Post-Gazette. La valutazione considera cultura aziendale, supporto ai dipendenti, opportunità di crescita e empowerment.
L'azienda ha ottenuto numerosi riconoscimenti nel 2025, tra cui Top Workplaces USA (quarto anno consecutivo), classificandosi al terzo posto nella categoria Healthcare Industry, e ha ricevuto cinque Culture Excellence Awards per Innovazione, Equilibrio tra lavoro e vita privata, Compensazione e benefici, Leadership, e Scopo e Valori.
Castle Biosciences (Nasdaq: CSTL) ha sido nombrada como Top Workplace de Greater Pittsburgh por The Pittsburgh Post-Gazette, basada en comentarios anónimos de los empleados. El reconocimiento evalúa factores de la cultura laboral, como apoyo a los empleados, oportunidades de crecimiento y empoderamiento.
La empresa ha obtenido múltiples reconocimientos laborales en 2025, incluyendo Top Workplaces USA (cuarto año consecutivo), situándose en el tercer puesto de la categoría Healthcare Industry, y recibiendo cinco Culture Excellence Awards por Innovación, Flexibilidad entre el trabajo y la vida, Compensación y Beneficios, Liderazgo y Propósito y Valores.
Castle Biosciences (Nasdaq: CSTL)는 The Pittsburgh Post-Gazette가 직원들의 익명 피드백을 바탕으로 선정한 Greater Pittsburgh Top Workplace에 이름을 올렸습니다. 이 인정은 직원 지원, 성장 기회, 권한 부여 등 직장 문화 요인을 평가합니다.
회사는 2025년에 다수의 직장상을 수상했으며, Top Workplaces USA(4년 연속) 포함, Healthcare Industry 부문에서 3위를 차지했고, 혁신(Innovation), 일과 삶의 균형(Work-Life Flexibility), 보상 및 혜택(Compensation & Benefits), 리더십(Leadership), 목표 및 가치(Purpose & Values) 부문에서 다섯 개의 Culture Excellence Awards를 수상했습니다.
Castle Biosciences (Nasdaq: CSTL) a été nommée Top Workplace de Greater Pittsburgh par The Pittsburgh Post-Gazette, sur la base des retours anonymes des employés. Cette reconnaissance évalue des facteurs de culture d'entreprise tels que le soutien aux employés, les opportunités de développement et l'autonomisation.
L'entreprise a obtenu de multiples distinctions en 2025, notamment Top Workplaces USA (quatrième année consécutive), se classant troisième dans la catégorie Healthcare Industry, et a reçu cinq Culture Excellence Awards pour l'Innovation, l'Équilibre travail-vie personnelle, la Rémunération et les Avantages, le Leadership et la Mission & les Valeurs.
Castle Biosciences (Nasdaq: CSTL) wurde vom Pittsburgh Post-Gazette basierend auf anonymem Feedback der Mitarbeiter als Top Workplace der Greater Pittsburgh ausgezeichnet. Die Anerkennung bewertet Faktoren der Unternehmenskultur wie Mitarbeiterunterstützung, Entwicklungsmöglichkeiten und Empowerment.
Das Unternehmen hat 2025 mehrere Workplace-Auszeichnungen erhalten, darunter Top Workplaces USA (vierter aufeinander folgender Jahr), Rang drei in der Kategorie Healthcare Industry, und fünf Culture Excellence Awards für Innovation, Work-Life-Flexibility, Compensation & Benefits, Leadership und Purpose & Values.
Castle Biosciences (Nasdaq: CSTL) تمت تسميتها كأفضل مكان عمل في منطقة بيتسبيرغ الكبرى من قبل The Pittsburgh Post-Gazette استناداً إلى تعليقات موظفين مجهولة. التقييم يأخذ بعين الاعتبار عوامل ثقافة مكان العمل بما في ذلك دعم الموظفين وفرص النمو وتمكينهم.
حصلت الشركة في عام 2025 على عدة جوائز مكان عمل، بما في ذلك Top Workplaces USA (السنة الرابعة على التوالي)، وتبوأت المركز الثالث في فئة Healthcare Industry، وتلقت خمس جوائز Culture Excellence Awards في مجالات الابتكار، التوازن بين العمل والحياة، التعويض والمزايا، القيادة، والهدف والقيم.
Castle Biosciences (纳斯达克: CSTL) 已被《匹兹堡邮报》授予“大 Pittsburgh 大区最佳工作场所”称号，基于员工的匿名反馈。该认可是评估工作场所文化因素，包括员工支持、成长机会及授权感。
该公司在2025年获得多项工作场所荣誉，其中包括 Top Workplaces USA（连续第四年）、在 Healthcare Industry 类别中名列第三，以及因创新、工作与生活平衡、薪酬与福利、领导力，以及目标与价值观五项获得 Culture Excellence Awards。
- None.
- None.
FRIENDSWOOD, Texas, Sept. 23, 2025 (GLOBE NEWSWIRE) -- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that it has been recognized as a Greater Pittsburgh Top Workplace by The Pittsburgh Post-Gazette. The designation is based exclusively on anonymous employee feedback gathered through a third-party survey. The confidential survey measures several aspects of workplace culture designed to be indicative of employee satisfaction and engagement, including feeling respected and supported, enabled to grow and empowered to execute.
“This recognition belongs to our employees, whose voices and feedback shape the culture we are proud to celebrate today,” said Derek Maetzold, president and chief executive officer of Castle Biosciences. “Their passion and commitment to improving patient care are the foundation of Castle’s success.”
Castle is among just 89 companies honored with a Greater Pittsburgh Top Workplaces award in 2025. This distinction adds to eight other Top Workplaces accolades the Company has received this year:
- Top Workplaces USA (four consecutive years)
- Top Workplaces Healthcare Industry (three consecutive years), ranking third among other recognized companies in its size bracket in 2025
- Top Workplaces Arizona, from AZ Central (four consecutive years)
- Five Top Workplaces Culture Excellence Awards in the areas of Innovation, Work-Life Flexibility, Compensation & Benefits, Leadership and Purpose & Values
The comprehensive list of 2025 Greater Pittsburgh Top Workplaces can be viewed here.
About Castle Biosciences
Castle Biosciences (Nasdaq: CSTL) is a leading diagnostics company improving health through innovative tests that guide patient care. The Company aims to transform disease management by keeping people first: patients, clinicians, employees and investors.
Castle’s current portfolio consists of tests for skin cancers, Barrett’s esophagus and uveal melanoma. Additionally, the Company has active research and development programs for tests in these and other diseases with high clinical need, including its test in development to help guide systemic therapy selection for patients with moderate-to-severe atopic dermatitis seeking biologic treatment. To learn more, please visit www.CastleBiosciences.com and connect with us on LinkedIn, Facebook, X and Instagram.
DecisionDx-Melanoma, DecisionDx-CMSeq, i31-SLNB, i31-ROR, DecisionDx-SCC, MyPath Melanoma, TissueCypher, DecisionDx-UM, DecisionDx-PRAME and DecisionDx-UMSeq are trademarks of Castle Biosciences, Inc.
Investor Contact:
Camilla Zuckero
czuckero@castlebiosciences.com
Media Contact:
Allison Marshall
amarshall@castlebiosciences.com
Source: Castle Biosciences Inc.
FAQ
What recognition did Castle Biosciences (CSTL) receive in Pittsburgh for 2025?
How many workplace awards has Castle Biosciences (CSTL) received in 2025?
What is Castle Biosciences' (CSTL) track record with Top Workplaces USA award?
What specific Culture Excellence Awards did Castle Biosciences (CSTL) receive in 2025?
